bs-3613R

antibody from Bioss

Targeting: EIF2S1 EIF-2alpha, EIF2, EIF2A

Western blot (Recommended by provider)

Immunocytochemistry (Recommended by provider)

Immunohistochemistry (Recommended by provider)

Antibody Data

Product number

bs-3613R

Provider

Bioss

Proper citation

Bioss Cat#bs-3613R, RRID:AB_10857393

Product name

eIF2 alpha Polyclonal Antibody

Antibody type

Polyclonal

Description

KLH conjugated synthetic peptide derived from human eIF2 alpha

Reactivity

Human, Mouse, Rat

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

100ul

Concentration

1ug/ul

Storage

Aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide. Store at -20°C for 12 months.

References

Submitted references

Enhanced antitumor effect of combination of annexin A1 knockdown and bortezomib treatment in multiple myeloma in vitro and in vivo.

Jia C, Kong D, Guo Y, Li L, Quan L
Biochemical and biophysical research communications 2018 Nov 2;505(3):720-725

---

Targeting the Wnt-Regulatory Protein CTNNBIP1 by microRNA-214 Enhances the Stemness and Self-Renewal of Cancer Stem-Like Cells in Lung Adenocarcinomas.

Qi W, Chen J, Cheng X, Huang J, Xiang T, Li Q, Long H, Zhu B
Stem cells (Dayton, Ohio) 2015 Dec;33(12):3423-36